ABOS - Acumen Pharmaceuticals GAAP EPS of -$0.26 November, 14 2022 04:11 PM Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals press release ( NASDAQ: ABOS ): Q3 GAAP EPS of -$0.26. Cash, cash equivalents and marketable securities of $200.2 million as of Sept. 30, 2022. For further details see: Acumen Pharmaceuticals GAAP EPS of -$0.26